Allworth Financial
DRUG icon

Allworth Financial’s Bright Minds Biosciences DRUG Stock Holding History

Allworth Financial’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.37K Hold
48
– – ﹤0.01% 4431
2026
Q2 		$3.37K Buy
48
+45
+1,500% +$3.53K ﹤0.01% 4307
2026
Q1 		$219 Buy
+3
New +$241 ﹤0.01% 4910

Other funds holding DRUG

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

Allworth Financial's DRUG Position: Q3 2026 in Review

Allworth Financial held its Bright Minds Biosciences (DRUG) position steady in Q3 2026 at 48 shares worth $3.37K. The position accounts for ﹤0.01% of the portfolio, ranked #4431.

Allworth Financial first reported a position in DRUG in Q1 2026 and has held it in 3 quarters since. 58 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.

  • Allworth Financial held 48 shares of Bright Minds Biosciences worth $3.37K as of Q3 2026.
  • Allworth Financial left its Bright Minds Biosciences share count unchanged in Q3 2026.
  • Bright Minds Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4431 holding.
  • Allworth Financial first reported a position in Bright Minds Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 58 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.